Shares of Avidity Biosciences surged to a record high Wednesday after the company showed its hand in the cardiovascular space.

Immunic, Inc. , a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced that the data ...

Nanoparticles that turn inflammation into propulsion power deliver targeted IBD treatment, enhancing precision and efficacy.

P13, a biosimilar of infliximab, in inflammatory bowel diseases: a systematic review and meta-analysis," published in the November 2024 issue of Gastroenterology by Hu et al. Since 2015, CT-P13, a ...

Researchers using machine learning discovered that variations in microbial load in the gut, influenced by age, sex, diet, and more, play a significant role in disease-related bacterial presence. This ...

Researchers at Case Western Reserve University have identified a new target to treat atherosclerosis, a condition where ...

In recent years, the role of gut microbiota has become the major area of focus in human health and diseases. Numerous studies have highlighted the importance of gut microbiota in the regulation of ...

The non-cystic fibrosis bronchiectasis market is driven by rising prevalence linked to respiratory infections, autoimmune diseases, and COPD. Increasing awareness among healthcare providers and ...

Brooke Abbott Abron faced significant barriers to diagnosis and adequate care for Crohn's disease, rooted in systemic racism ...

There are many reasons someone may get sick frequently, from your environment and lifestyle to genetics and underlying ...